Goldman Sachs’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.3M | Buy |
5,797,195
+1,875,654
| +48% | +$17.6M | 0.01% | 1091 |
|
|
2025
Q1 | $48.2M | Sell |
3,921,541
-2,028,996
| -34% | -$24.9M | 0.01% | 1082 |
|
|
2024
Q4 | $78.7M | Buy |
5,950,537
+4,338,485
| +269% | +$57.4M | 0.01% | 794 |
|
|
2024
Q3 | $31M | Buy |
1,612,052
+168,040
| +12% | +$3.23M | 0.01% | 1405 |
|
|
2024
Q2 | $29.6M | Buy |
1,444,012
+133,939
| +10% | +$2.75M | 0.01% | 1297 |
|
|
2024
Q1 | $31.2M | Buy |
1,310,073
+59,125
| +5% | +$1.41M | 0.01% | 1260 |
|
|
2023
Q4 | $27M | Sell |
1,250,948
-16,800
| -1% | -$363K | 0.01% | 1349 |
|
|
2023
Q3 | $18.4M | Buy |
1,267,748
+521,363
| +70% | +$7.57M | ﹤0.01% | 1570 |
|
|
2023
Q2 | $15.6M | Buy |
746,385
+255,612
| +52% | +$5.35M | ﹤0.01% | 1725 |
|
|
2023
Q1 | $10.4M | Buy |
490,773
+52,530
| +12% | +$1.11M | ﹤0.01% | 1981 |
|
|
2022
Q4 | $11.2M | Sell |
438,243
-129,838
| -23% | -$3.3M | ﹤0.01% | 2047 |
|
|
2022
Q3 | $13.7M | Buy |
568,081
+21,842
| +4% | +$525K | ﹤0.01% | 1890 |
|
|
2022
Q2 | $10.5M | Buy |
546,239
+137,976
| +34% | +$2.65M | ﹤0.01% | 2093 |
|
|
2022
Q1 | $7.1M | Buy |
408,263
+44,602
| +12% | +$775K | ﹤0.01% | 2519 |
|
|
2021
Q4 | $7.96M | Buy |
363,661
+43,553
| +14% | +$953K | ﹤0.01% | 2447 |
|
|
2021
Q3 | $6.12M | Sell |
320,108
-756,660
| -70% | -$14.5M | ﹤0.01% | 2645 |
|
|
2021
Q2 | $18.5M | Buy |
1,076,768
+513,163
| +91% | +$8.81M | ﹤0.01% | 1796 |
|
|
2021
Q1 | $12.6M | Buy |
563,605
+9,171
| +2% | +$205K | ﹤0.01% | 2034 |
|
|
2020
Q4 | $12.3M | Buy |
554,434
+302,464
| +120% | +$6.73M | ﹤0.01% | 1908 |
|
|
2020
Q3 | $3.72M | Sell |
251,970
-185,492
| -42% | -$2.74M | ﹤0.01% | 2568 |
|
|
2020
Q2 | $6.48M | Buy |
437,462
+421,773
| +2,688% | +$6.25M | ﹤0.01% | 2196 |
|
|
2020
Q1 | $172K | Sell |
15,689
-46,353
| -75% | -$508K | ﹤0.01% | 3990 |
|
|
2019
Q4 | $545K | Buy |
62,042
+39,305
| +173% | +$345K | ﹤0.01% | 3618 |
|
|
2019
Q3 | $170K | Sell |
22,737
-3,231
| -12% | -$24.2K | ﹤0.01% | 3950 |
|
|
2019
Q2 | $241K | Buy |
25,968
+11,594
| +81% | +$108K | ﹤0.01% | 3793 |
|
|
2019
Q1 | $75K | Sell |
14,374
-38,968
| -73% | -$203K | ﹤0.01% | 4049 |
|
|
2018
Q4 | $237K | Sell |
53,342
-13,057
| -20% | -$58K | ﹤0.01% | 3683 |
|
|
2018
Q3 | $537K | Sell |
66,399
-8,716
| -12% | -$70.5K | ﹤0.01% | 3428 |
|
|
2018
Q2 | $527K | Buy |
75,115
+58,706
| +358% | +$412K | ﹤0.01% | 3497 |
|
|
2018
Q1 | $234K | Sell |
16,409
-42,338
| -72% | -$604K | ﹤0.01% | 3786 |
|
|
2017
Q4 | $515K | Buy |
+58,747
| New | +$515K | ﹤0.01% | 3447 |
|
|
2016
Q2 | – | Sell |
-26,500
| Closed | -$353K | – | 4629 |
|
|
2016
Q1 | $353K | Buy |
+26,500
| New | +$353K | ﹤0.01% | 3434 |
|